作者：
Christian,Rausch [1]
;
Maja,Rothenberg-Thurley [1]
;
Annika,Dufour [1]
;
Stephanie,Schneider [1]
;
Hanna,Gittinger [2]
;
Cristina,Sauerland [1]
;
Dennis,Görlich [3]
;
Utz,Krug [3]
;
Wolfgang E,Berdel [4]
;
Bernhard J,Woermann [5]
;
Wolfgang,Hiddemann [6]
;
Jan,Braess [1]
;
Michael,von Bergwelt-Baildon [7]
;
Karsten,Spiekermann [8]
;
Tobias,Herold [9]
;
Klaus H,Metzeler [1]
作者单位：
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
[1]
Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.
[2]
Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
[3]
Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany.
[4]
Department of Medicine A, University Hospital Münster, Münster, Germany.
[5]
German Society of Hematology and Oncology, Berlin, Germany.
[6]
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
[7]
German Cancer Research Center (DKFZ), Heidelberg, Germany.
[8]
Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.
[9]
Bavarian Cancer Research Center (BZKF), Munich, Germany.
[10]
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. tobias.herold@med.uni-muenchen.de.
[11]
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. tobias.herold@med.uni-muenchen.de.
[12]
German Cancer Research Center (DKFZ), Heidelberg, Germany. tobias.herold@med.uni-muenchen.de.
[13]
Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany. klaus.metzeler@medizin.uni-leipzig.de.
[14]
DOI
10.1038/s41375-023-01884-2
PMID
37041198
发布时间
2023-06-22
换一批
换一批
